Evidence map›Paper›PMID 27144456›Full record

ArticlePLoS pathogens2016

Mnn10 Maintains Pathogenicity in Candida albicans by Extending α-1,6-Mannose Backbone to Evade Host Dectin-1 Mediated Antifungal Immunity.

Shi Qun Zhang, Zui Zou, Hui Shen, Shuai Shuai Shen, Qi Miao, Xin Huang, Wei Liu, Li Ping Li, Si Min Chen, Lan Yan and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Loss of Fgr41 inInfection and immunity · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The secretorymLife · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. PreventingEmerging microbes & infections · 2020
    Article
  19. CoremBio · 2020
    Article
  20. Frontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Shi Qun ZhangShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Zui ZouDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai, PR China.
Hui ShenDepartment of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, Shanghai, PR China.
Shuai Shuai ShenDepartment of Dermatology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, PR China.
Qi MiaoDepartment of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, Shanghai, PR China.
Xin HuangDepartment of Dermatology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, PR China.
Wei LiuShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Li Ping LiShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Si Min ChenShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Lan YanR&D Center of New Drug, School of Pharmacy, Second Military Medical University, Shanghai, PR China.
Jun Dong ZhangShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Jing Jun ZhaoDepartment of Dermatology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, PR China.
Guo Tong XuShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Mao Mao AnShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Yuan Ying JiangShanghai Tenth People's Hospital, and Department of Pharmacology, Tongji University School of Medicine, Shanghai, PR China.
Shanghai Tenth People's Hospital · CNSecond Military Medical University · CNTongji University · CNChanghai Hospital · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cell wall is a dynamic structure that is important for the pathogenicity of Candida albicans. Mannan, which is located in the outermost layer of the cell wall, has been shown to contribute to the pathogenesis of C. albicans, however, the molecular mechanism by which this occurs remains unclear. Here we identified a novel α-1,6-mannosyltransferase encoded by MNN10 in C. albicans. We found that Mnn10 is required for cell wall α-1,6-mannose backbone biosynthesis and polysaccharides organization. Deletion of MNN10 resulted in significant attenuation of the pathogenesis of C. albicans in a murine systemic candidiasis model. Inhibition of α-1,6-mannose backbone extension did not, however, impact the invasive ability of C. albicans in vitro. Notably, mnn10 mutant restored the invasive capacity in athymic nude mice, which further supports the notion of an enhanced host antifungal defense related to this backbone change. Mnn10 mutant induced enhanced Th1 and Th17 cell mediated antifungal immunity, and resulted in enhanced recruitment of neutrophils and monocytes for pathogen clearance in vivo. We also demonstrated that MNN10 could unmask the surface β-(1,3)-glucan, a crucial pathogen-associated molecular pattern (PAMP) of C. albicans recognized by host Dectin-1. Our results demonstrate that mnn10 mutant could stimulate an enhanced Dectin-1 dependent immune response of macrophages in vitro, including the activation of nuclear factor-κB, mitogen-activated protein kinase pathways, and secretion of specific cytokines such as TNF-α, IL-6, IL-1β and IL-12p40. In summary, our study indicated that α-1,6-mannose backbone is critical for the pathogenesis of C. albicans via shielding β-glucan from recognition by host Dectin-1 mediated immune recognition. Moreover, our work suggests that inhibition of α-1,6-mannose extension by Mnn10 may represent a novel modality to reduce the pathogenicity of C. albicans.

Indexed as

AnimalsBlotting, WesternCandida albicansCandidiasisCell LineCell WallDectin-1Disease Models, AnimalFemaleFungal ProteinsHumansImmune EvasionLectins, C-TypeMannansMannoseMannosyltransferasesDectin-1Fungal ProteinsLectins, C-TypeMannansMannoseMannosyltransferases

Identifiers

PMID27144456
PMCPMC4856274
OpenAlexW2345739108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.